416 related articles for article (PubMed ID: 27563707)
1. Aptamer and its applications in neurodegenerative diseases.
Qu J; Yu S; Zheng Y; Zheng Y; Yang H; Zhang J
Cell Mol Life Sci; 2017 Feb; 74(4):683-695. PubMed ID: 27563707
[TBL] [Abstract][Full Text] [Related]
2. Nucleic acid aptamers for neurodegenerative diseases.
Bouvier-Müller A; Ducongé F
Biochimie; 2018 Feb; 145():73-83. PubMed ID: 29104136
[TBL] [Abstract][Full Text] [Related]
3. Aptamers targeting amyloidogenic proteins and their emerging role in neurodegenerative diseases.
Murakami K; Izuo N; Bitan G
J Biol Chem; 2022 Jan; 298(1):101478. PubMed ID: 34896392
[TBL] [Abstract][Full Text] [Related]
4. Potential roles of natural products in the targeting of proteinopathic neurodegenerative diseases.
Dash R; Jahan I; Ali MC; Mitra S; Munni YA; Timalsina B; Hannan MA; Moon IS
Neurochem Int; 2021 May; 145():105011. PubMed ID: 33711400
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic strategies for targeting neurodegenerative protein misfolding disorders.
Scannevin RH
Curr Opin Chem Biol; 2018 Jun; 44():66-74. PubMed ID: 29902695
[TBL] [Abstract][Full Text] [Related]
6. [Immunotherapy targeting misfolded proteins in neurodegenerative disease].
Kanemaru K
Brain Nerve; 2013 Apr; 65(4):469-74. PubMed ID: 23568995
[TBL] [Abstract][Full Text] [Related]
7. Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.
Hekmatimoghaddam S; Zare-Khormizi MR; Pourrajab F
Biofactors; 2017 Nov; 43(6):737-759. PubMed ID: 26899445
[TBL] [Abstract][Full Text] [Related]
8. Neurodegenerative diseases linked to misfolded proteins and their therapeutic approaches: A review.
Khanam H; Ali A; Asif M; Shamsuzzaman
Eur J Med Chem; 2016 Nov; 124():1121-1141. PubMed ID: 27597727
[TBL] [Abstract][Full Text] [Related]
9. In vivo aspects of protein folding and quality control.
Balchin D; Hayer-Hartl M; Hartl FU
Science; 2016 Jul; 353(6294):aac4354. PubMed ID: 27365453
[TBL] [Abstract][Full Text] [Related]
10. Molecular chaperone dysfunction in neurodegenerative diseases and effects of curcumin.
Maiti P; Manna J; Veleri S; Frautschy S
Biomed Res Int; 2014; 2014():495091. PubMed ID: 25386560
[TBL] [Abstract][Full Text] [Related]
11. Aptamer Technology and Its Applications in Bone Diseases.
Liu X; Hu J; Ning Y; Xu H; Cai H; Yang A; Shi Z; Li Z
Cell Transplant; 2023; 32():9636897221144949. PubMed ID: 36591965
[TBL] [Abstract][Full Text] [Related]
12. Protein misfolding and aggregation in neurodegenerative diseases: a review of pathogeneses, novel detection strategies, and potential therapeutics.
Gandhi J; Antonelli AC; Afridi A; Vatsia S; Joshi G; Romanov V; Murray IVJ; Khan SA
Rev Neurosci; 2019 May; 30(4):339-358. PubMed ID: 30742586
[TBL] [Abstract][Full Text] [Related]
13. The spread of prion-like proteins by lysosomes and tunneling nanotubes: Implications for neurodegenerative diseases.
Victoria GS; Zurzolo C
J Cell Biol; 2017 Sep; 216(9):2633-2644. PubMed ID: 28724527
[TBL] [Abstract][Full Text] [Related]
14. Generating aptamers by cell-SELEX for applications in molecular medicine.
Ye M; Hu J; Peng M; Liu J; Liu J; Liu H; Zhao X; Tan W
Int J Mol Sci; 2012; 13(3):3341-3353. PubMed ID: 22489154
[TBL] [Abstract][Full Text] [Related]
15. Recent Advances in Aptamer Discovery and Applications.
Zhang Y; Lai BS; Juhas M
Molecules; 2019 Mar; 24(5):. PubMed ID: 30866536
[TBL] [Abstract][Full Text] [Related]
16. Advances in SELEX and application of aptamers in the central nervous system.
Yang Y; Yang D; Schluesener HJ; Zhang Z
Biomol Eng; 2007 Dec; 24(6):583-92. PubMed ID: 17681489
[TBL] [Abstract][Full Text] [Related]
17. Aptamers as promising molecular recognition elements for diagnostics and therapeutics in the central nervous system.
McConnell EM; Holahan MR; DeRosa MC
Nucleic Acid Ther; 2014 Dec; 24(6):388-404. PubMed ID: 25296265
[TBL] [Abstract][Full Text] [Related]
18. Neurodegenerative disorders: dysregulation of a carefully maintained balance?
Swart C; Haylett W; Kinnear C; Johnson G; Bardien S; Loos B
Exp Gerontol; 2014 Oct; 58():279-91. PubMed ID: 25219768
[TBL] [Abstract][Full Text] [Related]
19. Protein aggregate spreading in neurodegenerative diseases: problems and perspectives.
Lee SJ; Lim HS; Masliah E; Lee HJ
Neurosci Res; 2011 Aug; 70(4):339-48. PubMed ID: 21624403
[TBL] [Abstract][Full Text] [Related]
20. Aptamers as Therapeutic Agents: Has the Initial Euphoria Subsided?
Haßel SK; Mayer G
Mol Diagn Ther; 2019 Jun; 23(3):301-309. PubMed ID: 31037641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]